Volume 19, Number 8—August 2013
Research
Comparison of 2 Assays for Diagnosing Rotavirus and Evaluating Vaccine Effectiveness in Children with Gastroenteritis
Table 2
Laboratory result | Children with AGE |
Healthy controls |
|||||
---|---|---|---|---|---|---|---|
Rotavirus EIA+, n = 158 | Rotavirus EIA–, n = 490 | p value† | All, n = 500 | p value‡ | p value§ | ||
Virus detected by qRT-PCR |
157 (99) |
65 (13) |
<0.001 |
24 (5) |
<0.001 |
<0.001 |
|
Of those with virus detected | |||||||
Median Ct value (range) | 18 (11–40) | 36 (23–45) | <0.001 | 32 (21–44) | <0.001 | 0.02 | |
G and P type determined | 155 (99) | 8 (12) | <0.001 | 12 (50) | <0.001 | <0.001 | |
Vaccine strain detected | 1 (1) | 0 | 0.52 | 11 (46) | <0.001 | <0.001 |
*Values are no. (%) except as indicated. AGE, acute gastroenteritis; EIA, enzyme immunoassay; +, positive; −, negative; qRT-PCR, semiquantitative reverse transcription PCR; Ct, cycle threshold.
†Children with specimens that are EIA+ vs. EIA− for rotavirus.
‡Children with specimens EIA+ for rotavirus vs. healthy children.
§Children with specimens EIA− for rotavirus vs. healthy children.
Page created: July 02, 2013
Page updated: July 02, 2013
Page reviewed: July 02, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.